VIRACEPT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Agouron. The primary component is Nelfinavir Mesylate.
| Product ID | 63010-010_03efb824-da3b-4490-b2cc-64d349c9d264 |
| NDC | 63010-010 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VIRACEPT |
| Generic Name | Nelfinavir Mesylate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1997-03-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020779 |
| Labeler Name | AGOURON |
| Substance Name | NELFINAVIR MESYLATE |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 1997-03-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020779 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1997-03-14 |
| Ingredient | Strength |
|---|---|
| NELFINAVIR MESYLATE | 250 mg/1 |
| SPL SET ID: | e72c2bc6-9462-4a2e-8e1d-b97592376cbd |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52959-289 | VIRACEPT | nelfinavir mesylate |
| 53808-0809 | Viracept | NELFINAVIR MESYLATE |
| 55289-477 | VIRACEPT | nelfinavir mesylate |
| 63010-010 | VIRACEPT | nelfinavir mesylate |
| 63010-027 | VIRACEPT | nelfinavir mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VIRACEPT 74683161 2007831 Live/Registered |
AGOURUN PHARMACEUTICALS, LLC 1995-06-01 |